# OnCo record paper-nxc-201-hbi0101-asherie-haematologica-2023 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-nxc-201-hbi0101-asherie-haematologica-2023/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-nxc-201-hbi0101-asherie-haematologica-2023" ;
  schema:name "Development and manufacture of novel locally produced anti-BCMA CAR T cells for the treatment of relapsed/refractory multiple myeloma: results from a phase I clinical trial (HBI0101)"@en ;
  schema:description "A hospital in Jerusalem built and made its own CAR-T cells against the myeloma protein BCMA; in the first 20 heavily treated patients, 75 percent responded and half went into complete remission, with only mild immune reactions."@en ;
  schema:url <https://onco.cc/key-papers/paper-nxc-201-hbi0101-asherie-haematologica-2023/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.3324/haematol.2022.281628>, <https://pubmed.ncbi.nlm.nih.gov/36200421/>, <https://clinicaltrials.gov/study/NCT04720313> ;
  schema:sameAs <https://doi.org/10.3324/haematol.2022.281628> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Asherie N, Kfir-Erenfeld S, Avni B, et al." ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:targets <https://onco.cc/targets/bcma/> ;
  onco:drugs <https://onco.cc/drugs/nxc-201-car-t/> ;
  onco:institutions <https://onco.cc/institutions/hadassah/> ;
  onco:trials <https://onco.cc/trials/nxc-201-mm/> ;
  onco:journals <https://onco.cc/journals/haematologica/> .